Structure Therapeutics (GPCR) Prepaid Assets (2022 - 2026)
Structure Therapeutics (GPCR) recorded quarterly Prepaid Assets of $32.1 million in Q1 2026, up 33.14% quarter-over-quarter from $24.1 million in Q4 2025, and up 151.92% on a YoY basis from $12.7 million in Q1 2025.
Structure Therapeutics (GPCR) Prepaid Assets (2022 - 2026) Analysis & Trends
Structure Therapeutics' Prepaid Assets history runs 5 years deep, the most recent figure standing at $32.1 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 151.92% year-over-year to $32.1 million; the TTM figure through Mar 2026 stood at $32.1 million (up 151.92% YoY), while the FY2025 annual figure was $24.1 million, up 213.35% from the prior year.
- Prepaid Assets was $32.1 million for Q1 2026 at Structure Therapeutics, up from $24.1 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $32.1 million in Q1 2026 to a low of $2.2 million in Q4 2022.
- Historically, Prepaid Assets has averaged $11.3 million across 5 years, with a median of $9.4 million in 2024.
- Biggest YoY gain for Prepaid Assets was 213.35% in 2025; the steepest drop was 1.32% in 2025.
- A 5-year view of Prepaid Assets shows it stood at $2.2 million in 2022, then soared by 179.58% to $6.3 million in 2023, then increased by 22.4% to $7.7 million in 2024, then soared by 213.35% to $24.1 million in 2025, then jumped by 33.14% to $32.1 million in 2026.
- The last three Prepaid Assets figures came in at $32.1 million (Q1 2026), $24.1 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Structure Therapeutics | 9.35 Bn | 9.35 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.09 Mn |
| Dec 31, 2025 | 24.11 Mn |
| Sep 30, 2025 | 14.98 Mn |
| Jun 30, 2025 | 12.80 Mn |
| Mar 31, 2025 | 12.74 Mn |
| Dec 31, 2024 | 7.69 Mn |
| Sep 30, 2024 | 8.37 Mn |
| Jun 30, 2024 | 10.50 Mn |
| Mar 31, 2024 | 12.91 Mn |
| Dec 31, 2023 | 6.29 Mn |
| Sep 30, 2023 | 4.54 Mn |
| Jun 30, 2023 | 3.64 Mn |
| Mar 31, 2023 | 5.29 Mn |
| Dec 31, 2022 | 2.25 Mn |